NCT06577753 REspiratory diSEAse cohoRt Studies of CHinese Medicine for ILD (RESEARCH-ILD)
| NCT ID | NCT06577753 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Henan University of Traditional Chinese Medicine |
| Condition | Interstitial Lung Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2024-04-15 |
| Primary Completion | 2029-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2024-04-15 with a primary completion date of 2029-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is a traditional Chinese medicine cohort for interstitial lung disease（ILD） in China, including at least 5000 patients with ILD and followed up for at least 5 years. The aim is to focus on the demographic characteristics, clinical features, disease occurrence and development characteristics, TCM syndrome evolution patterns, and clinical efficacy of TCM treatment for ILD in the real world.
Eligibility Criteria
Inclusion Criteria: 1. Patients who meet the diagnosis of ILD; 2. Age≥18 years old; 3. Ability to provide independent informed consent. Exclusion Criteria: Patients with acute ILD caused by known reasons, but the lesions disappear within 2 weeks after treatment. Example: Interstitial pneumonia caused by infections such as mycoplasma/virus, and those who recover after treatment are excluded.
Contact & Investigator
Jian-sheng Li, Professor
STUDY CHAIR
The First Affiliated Hospital of Henan University of Traditional Chinese Medicine
Frequently Asked Questions
Who can join the NCT06577753 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Interstitial Lung Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06577753 currently recruiting?
Yes, NCT06577753 is actively recruiting participants. Contact the research team at yxqshi@163.com for enrollment information.
Where is the NCT06577753 trial being conducted?
This trial is being conducted at Zhengzhou, China.
Who is sponsoring the NCT06577753 clinical trial?
NCT06577753 is sponsored by Henan University of Traditional Chinese Medicine. The principal investigator is Jian-sheng Li, Professor at The First Affiliated Hospital of Henan University of Traditional Chinese Medicine. The trial plans to enroll 5,000 participants.